AI and Digital Tools in Dermatology: Addressing Access and Misinformation

By afschroeder • February 21, 2026

du Crest D, Madhumita M, Enbiale W, Ruiz Postigo JA, Malvehy J, Wongvibulsin S, Gupta S, Kittler H, Skayem C, Mahto A, Adamson AS, Lipoff JB, Papier A, Cartier H, Garson S, Freeman E. AI and Digital Tools in Dermatology: Addressing Access and Misinformation. JMIR Dermatol. 2026 Feb 20;9:e79044. doi: 10.2196/79044. PMID: 41719483; PMCID: PMC12923100.

Tags: AI, AI in health care, Artificial intelligence, Dermatology, dermatology, digital dermatology, digital health, ethical AI, global health, health tech, Large language model, LLM, misinformation, Publications, radical dermatology, Resident, skin, Social media, teledermatology

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype

Assan F, Tragin M, Marella S, Lipecka J, Roger K, Zarhrate M, Bondet V, Nguyen V, Akroun F, Nitschké P, Guerrera IC, Bole C, Izmiryan[...]

A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score

Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, Nong Y, Armstrong AW. A practical inflammatory blood-cell marker for cardiovascular risk stratification[...]

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials

Stein Gold L, Armstrong AW, Soung J, Vender RB, González Cantero Á, Hoffmann M, Guenthner ST, Hong HC, Murrell DF, Song EJ, Kircik L, Augustin[...]